NCT06168955View on ClinicalTrials.gov

Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease (HO-MA)

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Alzheimer Disease
Interventions
OTHER

skin biopsy

skin biopsy for cell culture and N-homocysteinylation study

Trial Locations (1)

54000

Centre Hospitalier Régional Universitaire de Nancy, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06168955 - Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease (HO-MA) | Biotech Hunter | Biotech Hunter